Long noncoding RNA LINC00467 facilitates the progression of acute myeloid leukemia by targeting the miR-339/SKI pathway

References

• Ferrara F. Unanswered questions in acute myeloid leukaemia. Lancet Oncol. 2004;5(7):443–450.
   PubMed Web of Science ®Google Scholar
• Duy C, Teater M, Garrett-Bakelman FE, et al. Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML. Cancer Discov. 2019;9(7):872–889.
   PubMed Web of Science ®Google Scholar
• Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2:16010.
   PubMed Web of Science ®Google Scholar
• Estey E, Dohner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894–1907.
   PubMed Web of Science ®Google Scholar
• Baccelli I, Gareau Y, Lehnertz B, et al. Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell. 2019;36(1):84–99.e88.
   PubMed Web of Science ®Google Scholar
• Wang H, Cao Y, Shu L, et al. Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes. J Cell Mol Med. 2020;24(2):1399–1412.
   PubMed Web of Science ®Google Scholar
• Ma XY, Ma Y, Zhou H, et al. Identification of the lncRNA-miRNA-mRNA network associated with gastric cancer via integrated bioinformatics analysis. Oncol Lett. 2019;18(6):5769–5784.
   PubMed Web of Science ®Google Scholar
• Ma J, Yan H, Zhang J, et al. Long-chain non-coding RNA (lncRNA) MT1JP suppresses biological activities of lung cancer by regulating miRNA-423-3p/Bim axis. Med Sci Monit. 2019;25:5114–5126.
   PubMed Web of Science ®Google Scholar
• Hu N, Chen L, Wang C, et al. MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in acute myeloid leukemia cells. Biomed Pharmacother. 2019;112:108720.
   PubMed Web of Science ®Google Scholar
• Yang T, Jin X, Lan J, et al. Long non-coding RNA SNHG16 has Tumor suppressing effect in acute lymphoblastic leukemia by inverse interaction on hsa-miR-124-3p. IUBMB Life. 2019;71(1):134–142.
   PubMed Web of Science ®Google Scholar
• Zhao C, Wang S, Zhao Y, et al. Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia. J Cell Physiol. 2019;234(5):6161–6172.
   PubMed Web of Science ®Google Scholar
• Zhao TF, Jia HZ, Zhang ZZ, et al. LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemia. Mol Med Rep. 2017;16(3):3687–3693.
   PubMed Web of Science ®Google Scholar
• Ding H, Luo Y, Hu K, et al. Linc00467 promotes lung adenocarcinoma proliferation via sponging miR-20b-5p to activate CCND1 expression. Onco Targets Ther. 2019;12:6733–6743.
   PubMed Web of Science ®Google Scholar
• He X, Li S, Yu B, et al. Up-regulation of LINC00467 promotes the tumourigenesis in colorectal cancer. J Cancer. 2019;10(25):6405–6413.
   PubMed Web of Science ®Google Scholar
• Jiang W, Cheng X, Wang T, et al. LINC00467 promotes cell proliferation and metastasis by binding with IGF2BP3 to enhance the mRNA stability of TRAF5 in hepatocellular carcinoma. J Gene Med. 2020;22(3):e3134.
   PubMed Web of Science ®Google Scholar
• Beck D, Thoms JAI, Palu C, et al. A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients. Leukemia. 2018;32(2):263–272.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang L, Wu Q, et al. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p. Stem Cell Res Ther. 2018;9(1):109.
   PubMedGoogle Scholar
• Weng R, Lu C, Liu X, et al. Long noncoding RNA-1604 orchestrates neural differentiation through the miR-200c/ZEB axis. Stem Cells. 2018;36(3):325–336.
   PubMed Web of Science ®Google Scholar
• Fayyad-Kazan H, Bitar N, Najar M, et al. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med. 2013;11(1):31.
   PubMedGoogle Scholar
• Ritter M, Kattmann D, Teichler S, et al. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia. Leukemia. 2006;20(3):437–443.
   PubMed Web of Science ®Google Scholar
• Dwyre DM, Osman M. AML with inv(16) with numerous Charcot-Leyden crystals. Blood. 2019;134(21):1876.
   PubMed Web of Science ®Google Scholar
• Dubois A, Furstoss N, Calleja A, et al. LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. Leukemia. 2019;33(6):1501–1513.
   PubMed Web of Science ®Google Scholar
• Drusbosky LM, Vidva R, Gera S, et al. Predicting response to BET inhibitors using computational modeling: a BEAT AML project study. Leuk Res. 2019;77:42–50.
   PubMed Web of Science ®Google Scholar
• De Moerloose B, Reedijk A, de Bock GH, et al. Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: results from protocol DB AML-01. Pediatr Blood Cancer. 2019;66(5):e27605.
   PubMed Web of Science ®Google Scholar
• Daver N, Schlenk RF, Russell NH, et al. Targeting FLT3 mutations in AML: review of current knowledge and evidence. Leukemia. 2019;33(2):299–312.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Xu X. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. J Cell Biochem. 2018;119(7):6296–6308.
   PubMed Web of Science ®Google Scholar
• Li GC, Xin L, Wang YS, et al. Long intervening noncoding 00467 RNA contributes to tumorigenesis by acting as a competing endogenous RNA against miR-107 in cervical cancer cells. Am J Pathol. 2019;189(11):2293–2310.
   PubMed Web of Science ®Google Scholar
• Hu T, Chong Y, Lu S, et al. miR-339 promotes development of stem cell leukemia/lymphoma syndrome via downregulation of the BCL2L11 and BAX proapoptotic genes. Cancer Res. 2018;78(13):3522–3531.
   PubMed Web of Science ®Google Scholar
• Chen J, Xu Y, Tao L, et al. MiRNA-26a contributes to the acquisition of malignant behaviors of doctaxel-resistant lung adenocarcinoma cells through targeting EZH2. Cell Physiol Biochem. 2017;41(2):583–597.
   PubMedGoogle Scholar
• Liu H, Ren G, Zhu L, et al. The upregulation of miRNA-146a inhibited biological behaviors of ESCC through inhibition of IRS2. Tumour Biol. 2016;37(4):4641–4647.
   PubMedGoogle Scholar
• Feld C, Sahu P, Frech M, et al. Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1. Nucleic Acids Res. 2018;46(7):3412–3428.
   PubMed Web of Science ®Google Scholar
• Teichler S, Illmer T, Roemhild J, et al. MicroRNA29a regulates the expression of the nuclear oncogene Ski. Blood. 2011;118(7):1899–1902.
   PubMed Web of Science ®Google Scholar
• Wang XQ, Crutchley JL, Dostie J. Shaping the genome with non-coding RNAs. Curr Genomics. 2011;12(5):307–321.
   PubMed Web of Science ®Google Scholar
• Bergmann JH, Spector DL. Long non-coding RNAs: modulators of nuclear structure and function. Curr Opin Cell Biol. 2014;26:10–18.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou J, Jiang C, et al. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway. Mol Oncol. 2019;13(11):2344–2360.
   PubMed Web of Science ®Google Scholar